Novavax Explained: Mechanism of Action and Immune Response

Corticosteroids act as anti-inflammatory agents decreasing mediator release and serving as neural modulators, extending anesthesia 1-6 hours. Alpha-2 agonists (clonidine/dexmedetomidine) provide analgesia and sedation with hemodynamic stability at therapeutic doses, though higher doses cause bradycardia/hypotension. Ketamine, an NMDA antagonist, decreases requirements but carries dissociation risks. Acetaminophen acts centrally for adjunctive analgesia. Dexmedetomidine is more selective than clonidine. These agents represent the current arsenal, with ongoing research exploring optimal dosing and clinical applications.

Local anesthetics (lidocaine, ester/amide types) block pain impulses for dental procedures, minor surgeries, labor, and diagnostic procedures. Administration includes injection (with vasoconstriction to prevent spread), spinal/epidural blocks, and topical application. Spinal/epidural monitoring requires watching for hypotension, anaphylaxis, seizures, dural punctures, respiratory depression, and hematoma. Post-spinal patients should lie supine 12 hours to prevent headaches. Side effects include CNS excitation (seizures), respiratory depression, hypotension, cardiovascular suppression, allergic reactions (more common with ester types), prolonged labor, fetal bradycardia, and urinary retention. Contraindications include pregnancy, supraventricular dysrhythmias, heart blocks, liver/kidney disease, and epinephrine near arteries. Adjuvant pain medications include tricyclic antidepressants (neuropathic pain), anticonvulsants (neuralgia), CNS stimulants (augment pain control), antihistamines (nausea, anxiety), glucocorticoids (inflammation, spinal cord compression), and bisphosphonates (bone pain).

Adjuvant therapy in medicine refers to complementary treatments administered alongside a primary treatment, not replacing it. In COVID-19 management, the established six-pillar treatment focuses on preventing complications: antibiotic therapy, corticosteroids, prophylactic anticoagulation, oxygen therapy, immunomodulation, and antiviral therapy. While vitamins C, D, and zinc are being studied as potential adjuvant therapies, they cannot replace the primary treatment and cannot be obtained through diet in therapeutic doses. The primary goal of COVID-19 treatment is to prevent complications like pneumonia, which typically develops around day 13 of infection.

Intrathecal opioids bind to substantia gelatinosa, requiring very low doses due to concentrated spinal fluid environment. Hydrophilic opioids (morphine, hydromorphone) have slower CSF crossing and longer duration, while lipophilic opioids (fentanyl, sufentanil) act rapidly and remain localized. Bupivacaine adjuvants reduce opioid side effects at concentrations <40 mg/mL and rates 10-15 mg/day. Clinical evidence shows combination therapy achieves >50% pain relief in 51% of patients at 12 months versus 31% with opioids alone, with lower dose escalation rates.

Adjuvant chemotherapy is administered after surgery to eliminate microscopic cancer cells that cannot be seen and removed by the surgeon. Neoadjuvant chemotherapy is given before surgery to shrink large tumors that cannot be completely removed initially. For aggressive cancers, doctors may prescribe both neoadjuvant and adjuvant chemotherapy, which may involve different drugs: preparatory chemotherapy followed by surgery and then postoperative chemotherapy.

When evaluating vaccination safety, comparing it to other vaccinations is the wrong comparison. The correct comparison is between vaccinated and unvaccinated outcomes during the pandemic. The early Alpha/Delta situation showed unvaccinated people having worse outcomes, which is the correct comparison. Comparing vaccination to other vaccinations only signals that something is different and warrants deeper investigation, but it doesn't tell you whether vaccination is beneficial or harmful.

Founders of vaccinology violated basic scientific principles by entering research with predetermined conclusions rather than unbiased observation. They assumed introducing weakened pathogens would confer immunity without proper testing. Crucially, they never conducted proper control groups comparing inoculated versus uninoculated subjects. Louis Pasteur distinguished between 'street rabies' and 'laboratory rabies' to explain adverse reactions. Emil von Behring's diphtheria antitoxin was never properly tested against unprepared serum, and studies decades later showed no difference. The polio virus was never proven to cause the disease—experiments with monkeys showed no transmission. Polio-like structures exist in healthy individuals, meaning their presence alone cannot prove causation.

Among vaccines in Phase 3 trials, the Novavax vaccine has shown the highest antibody response levels. The Oxford-AstraZeneca vaccine demonstrates excellent tolerability. Russia's Sputnik V and Gamaleya vaccines show strong immune responses, with Sputnik V being administered as a single dose. China's Sinovac vaccine shows excellent safety profiles with both doses providing good tolerability. These comparative results help determine which vaccines may be most suitable for different populations and healthcare systems.

Systematic vaccinology differs from traditional vaccinology by emphasizing the role of adjuvants in combination with antigens and various routes of administration. Reverse vaccinology uses genetic maps of pathogens to synthesize needed antigens artificially, enabling creation of safe vaccines without live microorganisms. This approach allows for more effective immune activation and longer-lasting immunity. The current pandemic has renewed interest in systematic vaccinology and the importance of adjuvant development.

Vaccinology is defined as the study of vaccination, an empirical practice that is not truly scientific. The video traces the historical development of vaccination from Jenner's cowpox discovery to modern practices, noting that vaccination became a major societal event during the Covid pandemic, justifying unprecedented restrictions and coercive measures. The hosts explain that vaccination has always been empirical, proceeding by trial and error without scientific understanding of underlying mechanisms. They note that despite widespread acceptance, dissenting voices have always existed, and now more are emerging with hindsight. The hosts emphasize that vaccination represents a fundamental shift in human relationship with the microbiome, moving from natural encounters to artificial interventions.

The cuts that took place last year led to a drop of 30% of WHO capacity, which is not good for this region nor for the world. The priorities are to support public health services, support ministries of health, and ensure safety of all WHO staff. The WHO is also worried about chemicals, biological, and nuclear threats, which requires training and preemptive risk management. The WHO's Global Health Emergency Logistics Hub in the UAE is now temporarily on hold because of insecurity and airspace closures linked to the Strait of Hormuz. The hub has shown significant importance during the COVID pandemic and continues to do so. There are at least 50 emergency supply requests from 25 different countries expected to benefit around or even over 1.5 million people. The hub has created a backlog due to airspace closures, with the WHO in the process of prioritizing from this backlog including Gaza, Lebanon, Afghanistan, Syria, Somalia, and Sudan.

Global Health Reach specializes in last-mile logistics, the art and science of getting critical resources to the most remote and inaccessible places on Earth. They do not have a massive budget but understand that moving a specialist like Marcus Langston quickly and efficiently is the most cost-effective use of every dollar. One doctor in the right place at the right time could prevent an epidemic that would cost millions to manage after the fact. Prevention is always cheaper than response, but prevention requires speed, and speed requires investment.

The Q&A session addresses key challenges in global health. The foundation does not have federal funds, so it did not lose funding directly, but patients are not doing well because resources have shifted toward infectious diseases and other needs. The foundation works in 81 countries but its work is very centralized because cancer treatment is very specific, requiring oncologists who are typically few in many countries. The foundation has controls to approve hospitals as partners, and companies that partner for drug access dictate which countries the foundation can work in. Capacity to treat and diagnose is typically another limitation. The foundation tries to put systems and resources in place to help patients go to the hospital instead of decentralizing the program, though in some places like Kenya and Ethiopia, the foundation has successfully decentralized programs. Major logistics issues include shelf life regulations that vary by country and create challenges with suppliers' ability to provide required shelf life. Climate change impacts are significant, with extreme temperatures affecting where and how medicines are shipped. For example, medicines shipped from the US sometimes experience temperatures below what medicines need, forcing the use of expensive temperature control packages.

UPS targets becoming the leading provider of complex healthcare logistics, investing $17 million in cold chain capabilities and pursuing biopharmaceutical expertise. The $82 billion addressable market reflects growing demand for specialized temperature-controlled transportation. Beyond commercial opportunities, UPS extends its capabilities through humanitarian initiatives like drone-based vaccine delivery to Rwanda, demonstrating how logistics technology can address infrastructure gaps in developing regions and contribute to global health objectives.

This video discusses two key topics: (1) The importance of accountability in governance and the challenges of youth migration, with statistics showing 85% of youth leaving, and (2) The role of healthy foods in preventing metabolic diseases such as diabetes, cholesterol issues, and cardiovascular disease, while also highlighting international logistics services that connect countries like Ghana to the United States within 3-5 days.